RxDoctor Payments Data

Mohammad Nawabi

Hematology & Oncology · Orangeburg, SCNPI 1275554594

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.8% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,554 and has fallen 87.2% since, to $199 in 2025. That places this record below the midpoint for hematology & oncology clinicians in SC, where the typical reported total is $4,020.

$3,005in general payments, 2019–2025

Across 159 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$332
  • AstraZeneca$189
  • Incyte Corporation$184
  • E.r. Squibb & Sons, L.L.C.$150
  • Gilead$148
  • Sanofi$137
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$2,84995%
  • Education$1565%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,005 in reported general payments places this provider in the 45th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Other hematology & oncology in Orangeburg

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →